STROBE-based methodology for detection of adverse events across multiple communities

Area of Science:

• Health Informatics
• Pharmacovigilance
• Public Health

Background:

• Active drug safety surveillance is crucial for monitoring medication risks and benefits.
• Existing surveillance systems require enhancement with novel health information technology.
• Collaboration among institutions is vital for developing robust public health tools.

Purpose of the Study:

• To develop innovative health information technology tools for a nationwide active drug safety surveillance system.
• To establish a standardized, systematic, and reproducible approach for drug safety monitoring.
• To detect both the risks and benefits of pharmaceutical interventions across diverse healthcare settings.

Main Methods:

• Collaboration between Partners Healthcare, eHealth Initiative (eHI), and the FDA.
• Development of novel health information technology tools.
• Adherence to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement guidelines.

Main Results:

• A nationwide effort is underway to create an active drug safety surveillance system.
• The STROBE statement provides a framework for structured data collection and analysis.
• The initiative aims to improve the detection of drug-related adverse events and benefits.

Conclusions:

• The collaboration is establishing a foundation for enhanced drug safety monitoring in the U.S.
• Standardized approaches like STROBE are essential for reliable pharmacovigilance.
• Health information technology advancements are key to improving patient safety and medication efficacy.